Given the pivotal role of ATM in activating the DNA damage response and repair pathways, it is likely that the anti-tumor effects observed when ATMi is combined with Ra-223 in prostate cancer bone metastases prevent efficient repair of the DNA strand breaks, leading to tumor cell death; however, before conclusions can be made, this requires further investigation. The gene discussed is ATM; the disease is neoplasm.